PIK3R1 and cancer: Some of the most significant cancer genes identified by MutSig2CV based on recurrence, such as PIK3R1 (mutated in 4% of the tumors), were not selected by our expression-based approach, highlighting the independence of recurrence- and expression-based approaches.